EVOFEM BIOSCIENCES, INC.
12400 High Bluff Drive, Suite 600
San Diego, CA 92130
March 9, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jane Park
RE: Evofem Biosciences, Inc.
Registration Statement on Form S-3
Filed March 4, 2021
File No. 333-253881
Request for Acceleration
Ladies and Gentlemen:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Evofem Biosciences, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to March 11, 2021, at 4:01 p.m. Eastern Time, or as soon as is practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call Melanie Ruthrauff Levy of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (858) 314-1873, with any comments or questions regarding the Registration Statement.
Very truly yours,
EVOFEM BIOSCIENCES, Inc.
/s/ Justin J. File
Justin J. File
Chief Financial Officer
cc: Melanie Ruthrauff Levy, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.